Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Work In Process (2016 - 2019)

Cryo Cell International (CCEL) has disclosed Work In Process for 5 consecutive years, with $140333.0 as the latest value for Q1 2019.

  • On a quarterly basis, Work In Process rose 28.34% to $140333.0 in Q1 2019 year-over-year; TTM through Feb 2019 was $140333.0, a 28.34% increase, with the full-year FY2018 number at $188085.0, up 93.48% from a year prior.
  • Work In Process was $140333.0 for Q1 2019 at Cryo Cell International, down from $188085.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $188085.0 in Q4 2018 to a low of $70226.0 in Q3 2015.
  • A 5-year average of $114010.1 and a median of $116287.0 in 2017 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: plummeted 50.87% in 2017, then soared 93.48% in 2018.
  • Cryo Cell International's Work In Process stood at $134727.0 in 2015, then plummeted by 39.2% to $81912.0 in 2016, then grew by 18.68% to $97210.0 in 2017, then soared by 93.48% to $188085.0 in 2018, then fell by 25.39% to $140333.0 in 2019.
  • Per Business Quant, the three most recent readings for CCEL's Work In Process are $140333.0 (Q1 2019), $188085.0 (Q4 2018), and $132506.0 (Q3 2018).